Managing patients with hematological malignancies during COVID-19 pandemic

Sahu, Kamal Kant; Černý, Jan

doi:10.1080/17474086.2020.1787147

Cited by 22 publications

(21 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The common comorbidities identified are obesity, hypertension, chronic lung disease, diabetes mellitus, cardiovascular disease, and malignancies. 6,7 Almost 4.9%-11.5% of the hospitalized patients (among all the age groups) require intensive care unit (ICU) admission and/or mechanical ventilation. Unfortunately, these figures increase to as high as 31% for individuals 75 years or older.…”

Section: Recognizing the Problem And Importance Of Dietitians During mentioning

confidence: 99%

“…Approximately 90% of the hospitalized patients had 1 or more underlying conditions. The common comorbidities identified are obesity, hypertension, chronic lung disease, diabetes mellitus, cardiovascular disease, and malignancies 6,7 . Almost 4.9%–11.5% of the hospitalized patients (among all the age groups) require intensive care unit (ICU) admission and/or mechanical ventilation.…”

Section: Recognizing the Problem And Importance Of Dietitians During mentioning

confidence: 99%

See 1 more Smart Citation

Challenges of Maintaining Optimal Nutrition Status in COVID‐19 Patients in Intensive Care Settings

Minnelli

Gibbs

Larrivee

et al. 2020

J Parenter Enteral Nutr

Self Cite

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has threatened patients, healthcare systems, and all countries across the globe with unprecedented challenges and uncertainties. According to the latest literature, most patients with COVID-19 have mild symptoms that do not require hospital admissions, and only a small percentage of those hospitalized require intensive care. In the intensive care unit (ICU), a registered dietitian nutritionist (RDN) assists the critical care team by formulating, executing, and monitoring the nutrition strategies and interventions to meet the unique requirements of extremely sick patients. However, because of the novelty of COVID-19, the situation is fluid and guidelines continue to be developed and updated. This article discusses the interim guidelines available for the nutrition support of ICU COVID-19 patients and the challenges the critical care team and RDN may face from a nutrition standpoint.

show abstract

Section: Recognizing the Problem And Importance Of Dietitians During mentioning

confidence: 99%

Section: Recognizing the Problem And Importance Of Dietitians During mentioning

confidence: 99%

Challenges of Maintaining Optimal Nutrition Status in COVID‐19 Patients in Intensive Care Settings

Minnelli

Gibbs

Larrivee

et al. 2020

J Parenter Enteral Nutr

Self Cite

View full text Add to dashboard Cite

show abstract

“…The study showed that 83.2% of the patients in the study had lymphopenia at presentation. Furthermore, lymphopenia emerged as a prognostic marker for COVID-19 [ 81 ]. A recent meta-analysis found 35–75% of patients to have lymphopenia, likely more so in non-survivors [ 56 , 61 ].…”

Section: White Blood Cells Abnormalities and Covid-19mentioning

confidence: 99%

A review on how to do hematology consults during COVID-19 pandemic

Sahu

Černý

2021

Blood Reviews

Self Cite

View full text Add to dashboard Cite

The ongoing COVID-19 pandemic is the most trending and talked topic across the World. From its point of origin in Wuhan, China to clinical laboratory at NIH, a mere six-month-old SARS-CoV-2 virus is keeping the clinicians, and scientists busy at various fronts. However, COVID-19 is an emerging and evolving disease and each day brings in more data, new figures, and findings from the field of clinical practice. The role of hematologists has been increasingly recognized during the current pandemic because of several reasons. Most important of them are the characteristic hematological findings of COVID-19 patients that also have prognostic implications and that were not seen in other viral infections. The treatment of hematological complications in COVID-19 patients is very challenging given the critical care setting. There are interim and limited guidelines thus far due to the novelty of the disease. As this remains to be a quite fluid situation, all the appropriate medical societies including the major hematology bodies are proposing initial and interim guidelines (e.g. ASH guideline). This puts a hematologist on consult service in a dubious position where, he/she must tailor the recommendations on case to case basis. The purpose of this review is to provide the background context about the impact of COVID-19 on the blood system and to summarize the current interim guidelines to manage the associated hematological issues in COVID-19 infection.

show abstract

“…In multiple myeloma, the European Myeloma Network recommends delaying autologous transplantation and extending induction therapy, especially in standard risk patients and those who respond adequately to induction [6]. Nonetheless, a failure to provide the most effective therapy in a timely manner may often result in irreversible relapse or progression of hematologic malignancies [7]. Some HCT centers have therefore decided to continue carrying out transplants, especially for patients without COVID-19 who have malignant disease [8,9].…”

Section: Introductionmentioning

confidence: 99%